Central African Republic vs Guinea-Bissau: Average cost of multi drug-resistant tuberculosis treatment
Central African Republic
1,043 constant 2022 US$
in 2024
Guinea-Bissau
1,120 constant 2022 US$
in 2024
Central African Republic rank
46th
Guinea-Bissau rank
43rd
Average cost of multi drug-resistant tuberculosis treatment over time
- Central African Republic
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 1,120 constant 2022 US$ against 1,043 constant 2022 US$ in Central African Republic, a difference of 77 constant 2022 US$.
That makes Guinea-Bissau's figure about 1.1 times Central African Republic's.
The two have swapped places 4 times across 7 shared years of data; in 2017 it was Guinea-Bissau ahead.
Central African Republic ranks 46th and Guinea-Bissau ranks 43rd of 92 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,461 constant 2022 US$ | 2,481 constant 2022 US$ | 1,020 constant 2022 US$ | Guinea-Bissau |
| 2020s | 1,080 constant 2022 US$ | 1,233 constant 2022 US$ | 152.5 constant 2022 US$ | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Central African Republic or Guinea-Bissau?
- Guinea-Bissau, at 1,120 constant 2022 US$ against 1,043 constant 2022 US$ in Central African Republic as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Central African Republic and Guinea-Bissau?
- 77 constant 2022 US$, with Guinea-Bissau ahead.
- How many years of comparable data are there for Central African Republic and Guinea-Bissau?
- 7 years are reported by both, from 2017 to 2024.
- How do Central African Republic and Guinea-Bissau rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Central African Republic ranks 46th and Guinea-Bissau ranks 43rd of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.